Midatech Pharma plc (MTPH) ORD GBP0.001
Share news, reports & tips
17 September 2021 12:28
(Sharecast News) - Drug delivery technology Midatech Pharma significantly narrowed interim losses in the six months ended 30 June ahead of discussions aimed at licensing its products to drugmakers.
29 June 2021 10:53
(Sharecast News) - Drug delivery technology company Midatech Pharma has raised £10m before expenses, it announced on Tuesday, to continue its formulation development work.
19 October 2020 12:52
(Sharecast News) - Biotechnology company Midatech Pharma announced "encouraging" headline results from a phase 1 study at the University of California, San Francisco (UCSF) in patients with diffuse...
27 July 2020 11:25
(Sharecast News) - Drug delivery technology company Midatech Pharma has raised £5m before expenses via a placing to investors in the UK, it announced on Monday, to advance and develop its...
21 July 2020 08:29
(Sharecast News) - Drug delivery technology company Midatech Pharma has entered into a research collaboration for the 'Q-Sphera' platform, it announced on Tuesday, with an unnamed European...
16 June 2020 15:32
(Sharecast News) - Drug delivery technology company Midatech Pharma reported a fall in total gross revenue to £0.7m in its final results on Tuesday, from £1.9m year-on-year.
8 June 2020 13:00
(Sharecast News) - Biotechnology research and development company Midatech Pharma has entered into a research collaboration with generic drugs giant Dr Reddy's Laboratories, it announced on Monday.
21 May 2020 15:54
(Sharecast News) - Biotechnology company Midatech Pharma announced the closing of its registered direct offering of 1,818,182 American depositary shares (ADS), each representing five of its ordinary shares,...
1 May 2020 11:17
(Sharecast News) - Midatech Pharma said it knew of no reason for a surge in its share price on Friday morning.
8 January 2020 15:51
(Sharecast News) - Biotechnology research and development company Midatech Pharma announced positive headline results from 'study 102' on Wednesday, which it said met its primary endpoints to...
8 October 2019 09:24
(Sharecast News) - Midatech Pharma on Tuesday announced that its MTD201 Phase 1 study for the treatment of acromegaly and neuroendocrine tumours has commenced.
20 September 2019 15:43
(Sharecast News) - Biotechnology company Midatech Pharma has received approval to commence a phase 1 study on MTD201, which it is developing for the treatment of acromegaly and neuroendocrine tumours (NET).
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.